The von Hippel-Lindau tumor suppressor targets to mitochondria

Cancer Research

Volumn 60, Issue 11, 2000, Pages 2816-2819

  Shiao, Yih Horng ^a   Resau, James H ^a,c   Nagashima, Kunio ^b   Anderson, Lucy M ^a   Ramakrishna, Gayatri ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c VAN ANDEL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CLEAR CELL CARCINOMA; KIDNEY CARCINOMA; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ANIMALS; CELL LINE; CYTOPLASM; EPITHELIAL CELLS; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; KIDNEY; LIGASES; LUMINESCENT PROTEINS; MICROSCOPY, CONFOCAL; MITOCHONDRIA; PLASMIDS; PROTEIN BIOSYNTHESIS; RATS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0034214361     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., Jr., and Goldberg, M. A. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA, 93: 10595-10599, 1996.
2. Ananth, S., Knebelmann, B., Gruning, W., Dhanabal, M., Walz, G., Stillman, I. E., and Sukhatme, V. P. Transforming growth factor β1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma. Cancer Res., 59; 2210-2216, 1999.
3. Maxwell, P. H., Wiesener, M. S., Chang, G-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., and Ratcliffe, P. J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-depen-dent proteolysis. Nature (Lond.), 399: 271-275, 1999.
4. Lisztwan, J., Imbert, G., Wirbelauer, C., Gstaiger, M., and Krek, W. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev., 13: 1822-1833, 1999.
5. Decker, H. J. H., Weidt, E. J., and Brieger, J. The von Hippel-Lindau tumor suppressor gene. Cancer Genet. Cytogenet., 93: 74-83, 1997.
6. Fehrenbach, H., Kasper, M., Haase, M., Schuh, D., and Muller, M. Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy. Anat. Rec., 254: 61-73, 1999.
7. Heine, U. I., Burmester, J. K., Flanders, K. C., Danielpour, D., Munoz, E. F., Roberts, A. B., and Sporn, M. B. Localization of transforming growth factor-β1 in mitochondria of murine heart and liver. Cell Regul. , 2: 467-477, 1991.
8. Magnani, M., Serafini, G., Antonelli, A., Malatesta, M., and Gazzanelli, G. Evidence for a particulate location of ubiquitin conjugates and ubiquitin-conjugating enzymes in rabbit brain. J. Biol. Chem., 266: 21018-21024, 1991.
9. Schwartz, A. L., Trausch, J. S., Ciechanover, A., Slot, J. W., and Geuze, H. Immunoelectron microscopic localization of the ubiquitin-activating enzyme E1 in HepG2 cells. Proc. Natl. Acad. Sci. USA, 89: 5542-5546, 1992.
10. Lodish, H., Baltimore, D., Berk, A., Zipursky, S. L., Matsudaira, P., and Darnell, J. Molecular Cell Biology, Ed. 3, pp. 745-752. New York: Scientific American Books, 1995.
11. Thoenes, W., Storkel, S., and Rumpelt, H. J. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). Pathol. Res. Pract., 181: 125-143, 1986.
12. Corless, C. L., Kibel, A. S., Iliopoulos, O., and Kaelin, W. G. Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues. Hum. Pathol., 28: 459-464, 1997.
13. Rasmussen, L., Battles, J. K., Ennis, W. H., Nagashima, K., and Gonda, M. A. Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus. Virology, 178: 435-451, 1990.
14. Shiao, Y-H., Rice, J. M., Anderson, L. M., Diwan, B. A., and Hard, G. C. von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors. J. Natl. Cancer Inst., 90: 1720-1723, 1998.
15. Los, M., Jansen, G. H., Kaelin, W. G., Lips, C. J. M., Blijham, G. H., and Voest, E. E. Expression pattern of the von Hippel-Lindau protein in human tissues. Lab. Investig., 75: 231-238, 1996.
16. Lee, S., Chen, D. Y. T., Humphrey, J. S., Gnarra, J. R., Linehan, W. M., and Klausner, R. D. Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc. Natl. Acad. Sci. USA, 93: 1770-1775, 1996.
17. Ye, Y., Vasavada, S., Kuzmin, I., Stackhouse, T., Zbar, B., and Williams, B. R. G. Subcellular localization of the von Hippel-Lindau disease gene product is cell cycle-dependent. Int. J. Cancer, 78: 62-69, 1998.
18. Lee, S., Neumann, M., Stearman, R., Stauber, R., Pause, A., Pavlakis, G. N., and Klausner, R. D. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein. Mol. Cell. Biol., 19: 1486-1497, 1999.
19. Erlandson, R. A., Shek, T. W. H., and Reuter, V. E. Diagnostic significance of mitochondria in four types of renal epithelial neoplasms: an ultrastructural study of 60 tumors. Ultrastruct. Pathol., 21: 409-417, 1991.
20. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Washington DC), 281: 1309-1312, 1998.